17311-31-8 Usage
Description
2,3-Quinoxalinedimethanol,1,4-dioxide is an organic compound with the molecular formula C8H8N2O4. It is a derivative of quinoxaline, which is a heterocyclic compound consisting of a fused benzene and pyrazine ring. 2,3-Quinoxalinedimethanol,1,4-dioxide has two hydroxyl groups attached to the 2nd and 3rd carbon atoms and a dioxide group at the 1,4-positions.
Uses
Used in Pharmaceutical Industry:
2,3-Quinoxalinedimethanol,1,4-dioxide is used as an intermediate compound for the synthesis of various pharmaceutical agents. Its unique structure allows for the development of new drugs with potential applications in treating different diseases.
Used in Antitubercular Applications:
2,3-Quinoxalinedimethanol,1,4-dioxide is used as an identifier for triazole and imidazole derivatives that have potential as antitubercular agents. Its ability to interact with these derivatives helps in the development of new drugs for the treatment of tuberculosis.
Used in Chemical Research:
2,3-Quinoxalinedimethanol,1,4-dioxide is also used in chemical research for understanding the properties and reactivity of quinoxaline derivatives. This knowledge can be applied to the design and synthesis of new compounds with specific applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 17311-31-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,3,1 and 1 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 17311-31:
(7*1)+(6*7)+(5*3)+(4*1)+(3*1)+(2*3)+(1*1)=78
78 % 10 = 8
So 17311-31-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H10N2O4/c13-5-9-10(6-14)12(16)8-4-2-1-3-7(8)11(9)15/h1-4,13-14H,5-6H2
17311-31-8Relevant articles and documents
Preparation method of 2, 3-quinoxaline-1, 4-dioxide
-
Paragraph 0008; 0044-0049, (2020/11/09)
The invention discloses a preparation method of 2, 3-quinoxaline-1, 4-dioxide, and belongs to the field of synthesis of medical intermediates. The method comprises the following steps: performing condensation cyclization on 1, 2-phenylenediamine serving as a raw material and 2, 3-butanedione to obtain 2, 3-dimethyl quinoxaline, and oxidizing the 2, 3-dimethyl quinoxaline with hydrogen peroxide under the action of a catalyst to obtain 2, 3-dimethyl quinoxaline-1, 4-dioxide; carrying out rearrangement and hydrolysis on the 2, 3-dimethyl quinoxaline-1, 4-dioxide and acid anhydride to obtain 2, 3-quinoxaline dimethanol; and finally, oxidizing the 2, 3-quinoxaline-1, 4-dioxide with hydrogen peroxide under the action of a catalyst to obtain the 2, 3-quinoxaline-1, 4-dioxide. By adopting the process route, the initial raw materials are easy to obtain, the cost is low, the total yield is as high as 64%, and industrial operation is facilitated.